Cilcare appoints Kevin Franck, PhD, MBA, as Head of US, General Manager North America

Oct 09, 2026

Posted by Cilcare

Phase 3 Study Results Highlighting Deucrictibant’s Rapid and Sustained Efficacy in Treating HAE Attacks Published in The Lancet

Oct 09, 2026

Posted by Pharvaris, Inc.

September Update: Antibody Industry Trends (Q3 2026 Insights, Trends & Analysis)

Oct 08, 2026

Posted by Biointron Biological

Foley Hoag Expands Denver Office with Addition of Three Partners

Oct 08, 2026

Posted by Foley Hoag LLP

Cilcare establishes its Japan subsidiary as its springboard for Asia-Pacific growth

Oct 07, 2026

Posted by Cilcare

Outsourced Pharma Capabilities Update – Large Molecule

Oct 07, 2026

Posted by Rentschler Biopharma Inc

Outsourced Pharma Capabilities Update – Cell Line Development

Oct 07, 2026

Posted by Rentschler Biopharma Inc

Real-World Analysis Highlighting HAE Disease Experience and Gaps in Treatment Satisfaction Published in Advances in Therapy

Oct 05, 2026

Posted by Pharvaris, Inc.

Harvard Griffin GSAS Biotech Club and Hatch.Bio Labs Open Submissions for Fall Pitch Competition

Oct 01, 2026

Posted by Hatch.Bio Labs

NCCN Foundation Patient Resources: Breast Cancer Awareness

Oct 01, 2026

Posted by National Comprehensive Cancer Network Foundation (NCCNF)